GlaxoSmithKline Pharmaceuticals Ltd. | Large-cap | Healthcare
₹3,173.10
-1.26%
| GlaxoSmithKline Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 37.5B
Gross Profit 23.6B 62.90%
Operating Income 11.1B 29.62%
Net Income 9.3B 24.74%

Balance Sheet Metrics

Total Assets 41.1B
Total Liabilities 21.6B
Shareholders Equity 19.5B
Debt to Equity 1.11

Cash Flow Metrics

Operating Cash Flow 12.7B
Free Cash Flow 12.7B

Revenue & Profitability Trend

GlaxoSmithKline Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 37.5B 34.4B 32.3B 32.6B 29.0B
Cost of Goods Sold 13.9B 14.2B 13.6B 14.5B 13.4B
Gross Profit 23.6B 20.2B 18.7B 18.1B 15.6B
Operating Expenses 6.0B 5.0B 4.8B 4.5B 3.3B
Operating Income 11.1B 8.4B 7.5B 7.0B 5.5B
Pre-tax Income 12.6B 8.2B 8.4B 7.8B 4.5B
Income Tax 3.3B 2.3B 2.3B 4.0B 1.7B
Net Income 9.3B 5.9B 6.1B 16.9B 3.6B
EPS (Diluted) - ₹34.83 ₹36.05 ₹100.04 ₹21.14

Income Statement Trend

GlaxoSmithKline Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 34.1B 28.0B 24.9B 37.1B 22.0B
Non-Current Assets 7.0B 7.6B 8.3B 9.3B 9.1B
Total Assets 41.1B 35.6B 33.3B 46.3B 31.1B
Liabilities
Current Liabilities 19.1B 15.2B 13.3B 17.0B 13.5B
Non-Current Liabilities 2.5B 2.5B 2.6B 2.7B 2.8B
Total Liabilities 21.6B 17.8B 15.9B 19.7B 16.4B
Equity
Total Shareholders Equity 19.5B 17.8B 17.4B 26.6B 14.8B

Balance Sheet Composition

GlaxoSmithKline Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 12.6B 9.6B 8.4B 24.8B 7.2B
Operating Cash Flow 12.7B 8.0B 8.0B 7.2B 5.3B
Investing Activities
Capital Expenditures -190.1M -267.5M -425.8M -334.6M -435.5M
Investing Cash Flow -1.6B -1.7B 6.2B -2.9B 3.6B
Financing Activities
Dividends Paid -7.5B -5.4B -15.3B -5.1B -6.8B
Financing Cash Flow -7.5B -5.4B -15.3B -5.1B -6.8B
Free Cash Flow 12.7B 5.5B 4.4B 7.8B 5.3B

Cash Flow Trend

GlaxoSmithKline Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 60.24
Forward P/E 56.91
Price to Book 28.61
Price to Sales 14.91
PEG Ratio 56.91

Profitability Ratios

Profit Margin 24.74%
Operating Margin 33.07%
Return on Equity 49.75%
Return on Assets 18.17%

Financial Health

Current Ratio 1.79
Debt to Equity 0.51
Beta 0.04

Per Share Data

EPS (TTM) ₹54.70
Book Value per Share ₹115.19
Revenue per Share ₹221.32

Financial data is updated regularly. All figures are in the company's reporting currency.